Bayer | BAYN - Le Bénéfice D'Exploitation





Le Bénéfice D'Exploitation Changement Date
Air Liquide EUR 2.84B 6.65B 2025-12
Akzo Nobel EUR 254M 37M 2026-03
Alcon AG USD 297M 16M 2026-03
Amarin USD -2.26M 564K 2025-12
Arkema EUR 80.9M 55.9M 2026-03
AstraZeneca USD 7.11B 4.14B 2026-03
BASF EUR 1.4B 1.58B 2026-03
Bayer EUR 3.53B 2.42B 2026-03
Beiersdorf EUR 504M 312M 2025-12
Corteva USD 1.16B 344.08M 2026-03
Covestro EUR -324M 5.72B 2025-12
Essilor EUR 1.38B 626M 2025-12
Fresenius EUR 713M 139M 2025-12
Fresenius Medical Care EUR 268M 395M 2026-03
Genmab DKK 260M 199M 2025-12
Givaudan CHF 610M 149M 2025-12
GlaxoSmithKline GBP 2.29B 856M 2026-03
GRIFOLS EUR 249M 26.38M 2026-03
Henkel EUR 1.42B 187M 2025-12
Hikma Pharmaceutical USD 348M 161M 2025-12
Johnson Matthey GBP 198M 56M 2026-06
Linde USD 2.38B 129M 2026-03
Lonza CHF 673M 243M 2025-06
Merck EUR 1.05B 572M 2026-03
Novartis USD 4.24B 171M 2026-03
Nutrien USD 377M 327M 2026-03
Philips EUR 302M 417M 2026-03
PPG Industries USD 450M 128M 2025-12
Roche Holding CHF 9.56B 3.8B 2025-12
Sanofi EUR 1.94B 239M 2026-03
SAP EUR 13.78B 11B 2026-03
Solvay EUR 118M 58M 2026-03
UCB EUR 1.29B 571M 2025-12
Umicore EUR 713.86M 409.56M 2025-12
Vinci EUR 6.05B 2.25B 2025-12